Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.
More research and oversight are needed before making permanent a pandemic policy that allows hospitals to treat acutely ill patients in their homes, according to new Cornell research.
People who refused to get vaccinated against COVID-19 had low levels of social trust, weak attachments to the rule of law, and were less willing to honor collective commitments to the greater good, according to Cornell research published today.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
In 2022-2023, the Center for Teaching Innovation awarded five Innovative Teaching & Learning Awards to Cornell faculty. With a goal of facilitating vibrant, challenging, and reflective learning experiences at Cornell, these awards sponsor projects across the colleges that explore new tools and emerging technologies, approaches, and teaching strategies. CTI is now accepting pre-applications for the 2023-2024 Innovative Teaching and Learning Awards – the deadline is April 17.
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
